Search results for "Drug Safety"
Dumping drugs puts traces of meds in taps
How can you keep the contents of one patient's medicine cabinet from getting into everyone's drinking water? Eventually, physicians could even be asked to pay attention to environmental impact when deciding which drugs to prescribe.
https://immattersacp.org/archives/2009/02/drugs.htm
1 Feb 2009
Polypill gets approval, fenofibric acid gets label change
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/01/fda.htm
1 Jan 2012
Statin warnings on liver enzymes, blood glucose revised
The warning labels on statin medications are being changed, the FDA announced last week.
https://immattersacp.org/weekly/archives/2012/03/06/7.htm
6 Mar 2012
Warning on PPIs and C. diff, contraceptive pill mixup
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/04/fda.htm
1 Apr 2012
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012
Ondansetron 32-mg dose pulled from market
The 32-mg, single intravenous dose of ondansetron hydrochloride (Zofran) has been pulled from the market due to its cardiac risks, the FDA recently announced.
https://immattersacp.org/weekly/archives/2012/12/11/9.htm
11 Dec 2012
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
New COPD treatment, warnings on insomnia and migraine drugs
This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more.
https://immattersacp.org/archives/2013/07/fda.htm
1 Jul 2013
Recommended: Move hydrocodone combo products to schedule II
This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014
Anxiolytic, hypnotic drugs may be associated with increased long-term mortality
Anxiolytic and hypnotic drugs may be associated with increased long-term mortality, according to a new study.
https://immattersacp.org/weekly/archives/2014/04/01/6.htm
1 Apr 2014